Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fresenius ProServe was a major business segment of the global healthcare group Fresenius, primarily encompassing the activities of Fresenius Vamed. The company specialized in the planning, development, and operational management of healthcare facilities, including hospitals and rehabilitation centers, on an international scale. Its service portfolio covered the entire value chain of healthcare real estate, from initial design and turnkey construction to technical services and total operational management. ProServe also played a significant role in providing post-acute and rehabilitative care across Europe. Following a strategic reorganization in 2023 under the "Future Fresenius" plan, the group transitioned to a new structure where ProServe's core activities are now primarily identified with the Vamed brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fresenius ProServe.